Transparency in Research: A Closer Look

In the pursuit of unbiased scientific revelation, transparency regarding potential conflicts of interest is paramount. This report delves into the declared competing interests of several researchers, shedding light on their affiliations and financial ties within the pharmaceutical industry.

Individual Declarations: A Summary

The following points summarize the declared competing interests of individual researchers:

• A.T.: Declares speakers’ honoraria from Merck Sharp & Dohme.
• R.J.S.: Declares personal fees from Marengo, Merck, Novartis, Pfizer and Replimune for consulting/advisory board activity, and research grant support to his institution from Merck.
• C.L.: Declares conflicts of interest with BMS, Pierre fabre, Sanofi, Novartis, MSD, Amgen, Merck Serono, Roche, Inflax and Pfizer.

In-Depth Examination of Competing Interests

A more detailed breakdown of individual declarations reveals the extent of industry involvement.

• S.P.: Receives research grants from Almirall, Pfizer, Regeneron, Sanofi, La Roche Posay Philogen, ISDIN and International School of Derma; consulting fees from Sanofi, Regeneron, ISDIN, L’Oreal, La Roche Posay and International School of Derma; personal fees from Sanofi, Sunpharma, Cantabria, Eucerin, ISDIN, L’Oreal, La Roche posay, Almirall, Avene and Pierre Fabre; and support for attending meetings and/or travel from Almirall, Cantabria and ISDIN.
• D.M.: declares personal fees from Novartis, Sun Pharma, Bayer HealthCare Pharmaceuticals Inc., Pierre-Fabre Oncology, Sanofi Genzyme, MSD Italia S.r.l., Roche and Skyline Dx B.V, and Sakura; and a grant from Regeneron.

Notable industry Ties

Some researchers report extensive relationships with multiple pharmaceutical companies, encompassing various forms of compensation and support.

• D.S.: Reports personal fees and non-financial support from Roche/Genentech, Merck Serono, Sanofi/Regeneron, SunPharma, Neracare, Replimune, Helsinn, OncoSec and InFlaRx; grants, personal fees and non-financial support from Amgen and Novartis; grants, personal fees, non-financial and other support from BMS; and personal fees from Merck sharp & Dohme, Immunocore, Incyte, 4SC, Pierre Fabre, Array BioPharma, Pfizer, Philogen, Regeneron, Nektar and Sandoz; outside the submitted work.

researchers Without Declared Conflicts

It is significant to note that not all researchers have declared competing interests.

• A.K., D.W. and L.V.v.d.P.-F.: Declare no competing interests.

Why Disclosure Matters

Disclosure of competing interests is crucial for maintaining the integrity of research. These disclosures allow readers to assess potential biases that may influence the interpretation or presentation of findings. While the presence of a conflict does not automatically invalidate research, it warrants careful consideration.